Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 589 05 637.9 |
96 | EP file number | EAKZ | 89 10 6657.3 |
97 | EP publication number | EPN | 392059 |
54 | Designation/title | TI | Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie. |
51 | IPC main class | ICM (ICMV) | A61K 31/13 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07C 211/38 (2006.01) |
22 | DE application date | DAT | Apr 14, 1989 |
96 | EP application date | EAT | Apr 14, 1989 |
43 | Date of first publication | OT | Oct 17, 1990 |
| Date of publication of grant | PET | Sep 15, 1993 |
71/73 | Applicant/owner | INH | Merz Pharma GmbH & Co. KGaA, 60318 Frankfurt, DE |
72 | Inventor | IN | Bormann, Joachim, Dr., W-6000 Frankfurt am Main 1, DE; Gold, Markus R., Dr., W-6085 Nauheim, DE; Schatton, Wolfgang, Dr., W-6236 Eschborn, DE |
| Address for service | | Merz Pharma GmbH & Co. KGaA, 60048 Frankfurt, DE |
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 102 99 048.4 |
97 | EP language of publication | ELANG | DE - Deutsch |
84 | Designated EP contracting states | EDS | AT, BE, CH, DE, ES, FR, GB, GR, IT, LI, LU, NL, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000000392059 Searchable text:
EP000000392059 Original document:
EP000000392059B1 Searchable text:
EP000000392059B1 |
43 | Date of first publication | EVT | Oct 17, 1990 |
| Date of the first transfer into DPMAregister | EREGT | Sep 26, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 5, 2024 (Show all update days)(Hide all update days)- Aug 5, 2024
- St.36: changed (technical change)
- Aug 16, 2019; May 29, 2019; Apr 24, 2019; Aug 3, 2017; Mar 18, 2015; Jul 30, 2013; May 9, 2013; Jan 19, 2013; Oct 10, 2012
- Historical data not available for this/these date(s)
- Sep 26, 2012
- Date of the first transfer into DPMAregister
|